Floatz logo

Minnelide

Cancer of Stomach

Minneamrita Therapeutics LLCPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Cancer of Stomach cohort.

Asset / SponsorPhaseRating
TEONANACATL
Psyence Australia Pty Ltd
Phase 2CCC
gz17-6.02
Genzada Pharmaceuticals USA, Inc.
Phase 1CC
HEPARIN
H. Lee Moffitt Cancer Center and Research Institute
N/AD

Same molecule, other indications

Minnelide is also rated in:

pancreatic adenosquamous carcinomaDormant
B
Indicative ·
57 / 100
View asset →
pancreatic neoplasmDormant
CCC
Indicative ·
53 / 100
View asset →
colorectal cancerDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →